Zenas BioPharma si garantisce 118 milioni di dollari per far progredire la sua ampia pipeline di terapie per le malattie autoimmuni
08 nov. 2022 12h03 HE
|
Zenas BioPharma (USA) LLC
I proventi serviranno a finanziare il programma di registrazione mondiale di Fase 3 per il principale prodotto candidato dell'azienda, Obexelimab, e a sostenere lo sviluppo clinico di altri programmi...
Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics
07 nov. 2022 16h00 HE
|
Zenas BioPharma
Proceeds to fund global Phase 3 registration program for the company’s lead product candidate, Obexelimab, and support the clinical development of other pipeline programsSeries B equity financing led...
Zenas BioPharma Mengangkat Simon Lowry, M.D. sebagai Direktur Bidang Medis
07 sept. 2022 08h00 HE
|
Zenas BioPharma
WALTHAM, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Zenas BioPharma, perusahaan biofarmasi global yang berkomitmen untuk menjadi yang terdepan dalam pengembangan dan komersialisasi terapi berbasis...
Zenas BioPharma ernennt Dr. Simon Lowry zum Chief Medical Officer
07 sept. 2022 08h00 HE
|
Zenas BioPharma
WALTHAM, Mass. und SHANGHAI, China, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Zenas BioPharma, ein globales biopharmazeutisches Unternehmen, das sich zum Ziel gesetzt hat, ein führendes Unternehmen in der...
Zenas BioPharma nomme Simon Lowry, M.D. au poste de directeur médical
07 sept. 2022 08h00 HE
|
Zenas BioPharma
WALTHAM, Mass. et SHANGHAI, Chine, 07 sept. 2022 (GLOBE NEWSWIRE) -- Zenas BioPharma, une société biopharmaceutique mondiale déterminée à devenir un leader dans le développement et la...
Zenas BioPharma Nomeia Simon Lowry, M.D. para Diretor Médico
07 sept. 2022 08h00 HE
|
Zenas BioPharma
WALTHAM, Mass. e SHANGHAI, China, Sept. 07, 2022 (GLOBE NEWSWIRE) -- A Zenas BioPharma, uma empresa biofarmacêutica global comprometida em se tornar líder no desenvolvimento e comercialização de...
Zenas BioPharma, 최고의학책임자에 Simon Lowry (M.D.) 선임
07 sept. 2022 08h00 HE
|
Zenas BioPharma
미국 매사추세츠주 월섬/중국 상하이, Sept. 07, 2022 (GLOBE NEWSWIRE) -- 전 세계 환자들을 위한 면역기반 치료제 개발 및 상용화에 매진하는 글로벌 바이오제약사인 Zenas BioPharma는 최고의학책임자에 Simon Lowry (M.D.)를 선임했다고 밝혔다. 20년 이상 초기 및 후기 임상 프로그램 설계 및 실행과 관련된...
Zenas BioPharma Melantik Simon Lowry, M.D. sebagai Ketua Pegawai Perubatan
07 sept. 2022 08h00 HE
|
Zenas BioPharma
WALTHAM, Mass. dan SHANGHAI, China, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Zenas BioPharma, sebuah syarikat biofarmaseutikal global yang komited untuk menjadi peneraju dalam pembangunan dan...
Zenas BioPharma任命Simon Lowry博士担任首席医学官
07 sept. 2022 08h00 HE
|
Zenas BioPharma
美国马萨诸塞州沃尔瑟姆和中国上海, Sept. 07, 2022 (GLOBE NEWSWIRE) -- 致力于成为世界各地患者免疫疗法开发与商业化领先企业的全球性生物制药公司Zenas BioPharma（泽纳仕生物医药），今日宣布任命Simon...
Zenas BioPharma Appoints Simon Lowry, M.D. as Chief Medical Officer
07 sept. 2022 08h00 HE
|
Zenas BioPharma
WALTHAM, Mass. and SHANGHAI, China, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of...